Acceptability of clinical trials on COVID-19 during pregnancy among pregnant women and healthcare providers: a qualitative study

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Marbán-Castro, Elena
• dc.contributor.author Pons-Duran, Clara
• dc.contributor.author García Otero, Laura
• dc.contributor.author Chen, Haily
• dc.contributor.author Herrera, Luis Bernardo
• dc.contributor.author Gil, María Del Mar
• dc.contributor.author Goncé, Ana
• dc.contributor.author Ferriols Pérez, Elena
• dc.contributor.author Rodríguez, Miguel Ángel
• dc.contributor.author Toro, Paloma
• dc.contributor.author Bardaji, Azucena
• dc.contributor.author González, Raquel
• dc.contributor.author Menéndez, Clara
• dc.contributor.author Enguita-Fernàndez, Cristina
• dc.date.accessioned 2022-06-15T06:31:14Z
• dc.date.available 2022-06-15T06:31:14Z
• dc.date.issued 2021
• dc.description.abstract Participation of pregnant women in clinical trials entails challenges mainly related to concerns about the risks for fetuses. We undertook a qualitative study from June to October 2020 to assess the acceptability of participating in COVID-19 clinical trials among pregnant women in Spain. Phenomenology and grounded theory were used as methodological approaches. Semi-structured interviews were conducted with 24 pregnant women and six healthcare providers. Women were unsure if pregnancy was a risk factor to acquire the infection or to develop severe disease and expressed the limited information they had received, which led to uncertainties and emotional suffering. They had concerns regarding participation in clinical trials on COVID-19, regardless of the drug under study. Healthcare providers alluded to the importance of involving pregnant women's relatives at the recruitment visit of the clinical trial. These findings may be useful to facilitate pregnant women's participation in clinical trials.
• dc.format.mimetype application/pdf
• dc.identifier.citation Marbán-Castro E, Pons-Duran C, García-Otero L, Chen H, Herrera LB, Gil MDM, et al. Acceptability of clinical trials on COVID-19 during pregnancy among pregnant women and healthcare providers: a qualitative study. Int J Environ Res Public Health. 2021 Oct 13; 18(20): 10717. DOI: 10.3390/ijerph182010717
• dc.identifier.doi http://dx.doi.org/10.3390/ijerph182010717
• dc.identifier.issn 1660-4601
• dc.identifier.uri http://hdl.handle.net/10230/53496
• dc.language.iso eng
• dc.publisher MDPI
• dc.rights Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword COVID-19
• dc.subject.keyword Acceptability
• dc.subject.keyword Clinical trial
• dc.subject.keyword Healthcare professionals
• dc.subject.keyword Perceptions
• dc.subject.keyword Pregnancy
• dc.title Acceptability of clinical trials on COVID-19 during pregnancy among pregnant women and healthcare providers: a qualitative study
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion